Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Lung Cancer”

371 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 371 results

Not applicableNot Yet RecruitingNCT06473870
What this trial is testing

Understanding Lung Cancer Related Risk Factors and Their Impact

Who this might be right for
Lung Cancer Screening
Biobizkaia Health Research Institute 6,160
Not applicableActive Not RecruitingNCT06942845
What this trial is testing

Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study

Who this might be right for
Lung Cancer, Non-Small CellPostoperative Cerebral Infarction
Xinghua Cheng 300
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Looking for participantsNCT06721286
What this trial is testing

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 70
Not applicableNot Yet RecruitingNCT07034365
What this trial is testing

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Fudan University 2,000
Not applicableUnknownNCT02075957
What this trial is testing

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Angers 192
Testing effectiveness (Phase 2)Active Not RecruitingNCT04716946
What this trial is testing

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer+5 more
Memorial Sloan Kettering Cancer Center 13
Not applicableLooking for participantsNCT07500376
What this trial is testing

Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery

Who this might be right for
Lung Cancer (Non-Small Cell)SarcopeniaMalnutrition Severe
Ondokuz Mayıs University 142
Not applicableEnded earlyNCT04040244
What this trial is testing

Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

Who this might be right for
PneumonitisNonsmall Cell Lung Cancer Stage III
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Not applicableStudy completedNCT00218179
What this trial is testing

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

Who this might be right for
Tobacco Use DisorderLung Cancer
University of Minnesota 200
Not applicableLooking for participantsNCT05732974
What this trial is testing

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
University Hospital, Toulouse 60
Early research (Phase 1)Ended earlyNCT00288054
What this trial is testing

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 24
Not applicableStudy completedNCT00596310
What this trial is testing

Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning

Who this might be right for
Lung Cancer
Susanne Arnold 531
Large-scale testing (Phase 3)Looking for participantsNCT02468024
What this trial is testing

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center 272
Not applicableLooking for participantsNCT06537726
What this trial is testing

Breath Analysis for the Detection of Invasive Fungal Infections

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich 130
Testing effectiveness (Phase 2)UnknownNCT05445310
What this trial is testing

Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Peking Union Medical College Hospital 114
Large-scale testing (Phase 3)Study completedNCT04442048
What this trial is testing

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Who this might be right for
CancerCovid-19
Canadian Cancer Trials Group 195
Large-scale testing (Phase 3)Not Yet RecruitingNCT06955325
What this trial is testing

Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations

Who this might be right for
Non-Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 270
Not applicableStudy completedNCT03305380
What this trial is testing

Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Maastricht Radiation Oncology 637
Next Page